Health Care & Life Sciences » Biotechnology | Rich Pharmaceuticals Inc.

Rich Pharmaceuticals Inc.

Rich Pharmaceuticals Inc.
Stock Exchange Other OTC
EPS
$0.01
Market Cap
$188.39 K
Shares Outstanding
1.88 B
Public Float
1.87 B

Profile

Address
145 South Fairfax Avenue
Los Angeles California 90036
United States
Employees -
Website http://www.richpharmaceuticals.com
Updated 07/08/2019
Rich Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages on developing innovative therapies in oncology. It develops RP-323 for the treatment of Hodgkin's lymphoma, Acute Myelogenous Leukemia, and to cause elevation of white blood cells in patients depleted of these elements due to various conditions. The company was founded on August 9, 2010 and is headquartered in Beverly Hills, CA.

Financials

View All
Created with Highcharts 5.0.14Rich Pharmaceuticals Inc.Net Income. Fiscal year is April-March. All values USD Thousands.31314 1334 1331 7681 7683 2413 2411 6921 6922013201520162017201801k2k3k4k5k
Created with Highcharts 5.0.14Rich Pharmaceuticals Inc.Sales/Revenue. Fiscal year is April-March. All values USD Thousands.00000000115115201320152016201720180255075100125

Carol A. Salvadore
Director
Ben Chang
Chairman, President, CEO, CFO & Secretary